Form D · Biotechnology
CIS BIOTECH INC
Atlanta, GA · CIK 0001439052
Offering snapshot reported Jul 14, 2010 · SEC filing
- Reported sold
- $50K Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jun 29, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 14, 2010 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Jun 30, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-144890
Source: Form D, filed Jul 14, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Svetlana Dambinova | Director |
| Galina Izykenova | Director, Executive |
| Robert R. Rhinehart | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1755 Logan's Knoll Ne
Atlanta, GA, 30329
Atlanta, GA, 30329